Dibact 500mg/62.5mg Injection
Marketer
Maneesh Pharmaceuticals Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Dibact 500mg/62.5mg Injection
Combiflox 500 mg/62.5 mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be strictly under medical guidance; adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration will aid recovery. Monitoring may include laboratory tests to assess treatment response.
Uses of Dibact 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Dibact 500mg/62.5mg Injection:
The medication will be administered by your physician or their assistant; self-medication is strictly prohibited.
Common Side effects of Dibact 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Dibact 500mg/62.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Dibact 500mg/62.5mg Injection works:
Ceftriaxone/Tazobactum 500 mg/62.5 mg Injection (Dibact) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Tazobactum counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol ingestion alongside Dibact 500 mg/62.5 mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Dibact 500 mg/62.5 mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Dibact 500 mg/62.5 mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Dibact 500 mg/62.5 mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Dibact 500 mg/62.5 mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication, Dibact 500 mg/62.5 mg, requires careful administration to individuals with advanced hepatic impairment. Dosage modification for this injection may be necessary. Physician consultation is advised. Altering the dose of Dibact 500 mg/62.5 mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Dibact 500mg/62.5mg Injection :
Omitting a scheduled dose of Dibact 500 mg/62.5 mg Injection warrants immediate physician consultation.
Facts to Know About Dibact 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently